# Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects

> **NCT05938452** · PHASE1 · COMPLETED · sponsor: **Forest Hills Lab** · enrollment: 40 (actual)

## Conditions studied

- Neurological Disorder

## Interventions

- **DRUG:** Glyceryl Tribenzoate

## Key facts

- **NCT ID:** NCT05938452
- **Lead sponsor:** Forest Hills Lab
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-12
- **Primary completion:** 2023-10-19
- **Final completion:** 2023-10-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05938452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05938452, "Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05938452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*